Category Pharma/Biotech

Indivi

Indivi Raises CHF15 Million to Advance Biomarker Discovery for Alzheimer’s and Neuroscience Drug Development

Indivi Secures CHF 15 Million to Advance Biomarker Discovery in Alzheimer’s and Neuroscience Drug Development Indivi, an independent TechBio company pioneering precision medicine solutions for neuroscience, today announced the successful…

Read MoreIndivi Raises CHF15 Million to Advance Biomarker Discovery for Alzheimer’s and Neuroscience Drug Development
Biomunex to Showcase Preclinical Findings on Its MAIT Engager Immuno-Oncology Platform at the 2025 SITC Annual Meeting

Biomunex to Showcase Preclinical Findings on Its MAIT Engager Immuno-Oncology Platform at the 2025 SITC Annual Meeting

Biomunex to Present Breakthrough Preclinical Data on Its MAIT Engager Immuno-Oncology Platform at the 2025 SITC Annual Meeting Biomunex Pharmaceuticals, a French biopharmaceutical company advancing the frontiers of cancer immunotherapy…

Read MoreBiomunex to Showcase Preclinical Findings on Its MAIT Engager Immuno-Oncology Platform at the 2025 SITC Annual Meeting

TAE Life Sciences’ Novel Boron Drugs for BNCT Show Enhanced Tumor Suppression with Immunotherapy in Preclinical Models

TAE Life Sciences’ Next-Generation Boron Drugs Show Promising Synergy with Immunotherapy in Preclinical BNCT Studies TAE Life Sciences (TLS), a leading biotechnology company focused on next-generation cancer therapies, today announced…

Read MoreTAE Life Sciences’ Novel Boron Drugs for BNCT Show Enhanced Tumor Suppression with Immunotherapy in Preclinical Models